Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-04-13 | Dr. William Jacob SavageChief Medical Officer | -5,73k | 380,45k | Automatic Disposition | 66,12 - 66,81 | 35,21k | -14,00% |
| 2026-04-13 | Ms. Jean M. FranchiCFO | -6,66k | 460,83k | Automatic Disposition | 69,00 - 69,24 | 0,00 | -100,00% |
| 2026-03-02 | Dr. William Jacob SavageChief Medical Officer | -7,38k | 486,07k | Automatic Disposition | 65,52 - 66,41 | 40,94k | -15,27% |
| 2026-02-25 | Ms. Jean M. FranchiCFO | -353,00 | 24,38k | Automatic Disposition | 69,06 | 6,66k | -5,04% |
| 2026-02-17 | Ms. Jean M. FranchiCFO | -4,08k | 256,15k | Verkauf | 62,86 | 7,01k | -36,76% |
| 2026-02-18 | Ms. Jean M. FranchiCFO | -7,08k | 463,57k | Automatic Disposition | 65,01 - 65,89 | 7,01k | -50,25% |
| 2026-02-17 | Dr. Rahul KharaChief Legal Officer & Secretary | -2,85k | 179,34k | Verkauf | 62,86 | 17,17k | -14,25% |
| 2026-02-17 | Ms. Pamela StephensonChief Commercial Officer | -5,53k | 347,68k | Verkauf | 62,86 | 9,50k | -36,80% |
| 2026-02-17 | Dr. William Jacob SavageChief Medical Officer | -3,26k | 204,67k | Verkauf | 62,86 | 44,27k | -6,85% |
| 2026-02-17 | Mr. Jonathan YuChief Opearating Officer | -3,23k | 203,10k | Verkauf | 62,86 | 19,32k | -14,32% |
| 2026-02-17 | Dr. John D. QuiselCEO, President & Director | -13,26k | 833,78k | Verkauf | 62,86 | 78,93k | -14,39% |
| 2026-01-20 | Dr. Rahul KharaChief Legal Officer & Secretary | -1.000,00 | 56,24k | Derivative Exercise and Sale | 13,50 - 69,74 | 13,79k | - |
| 2026-01-02 | Dr. Rahul KharaChief Legal Officer & Secretary | -6,50k | 423,72k | Derivative Exercise and Sale | 13,50 - 79,27 | 13,79k | - |
| 2025-12-22 | Dr. William Jacob SavageChief Medical Officer | 3,14k | 31,35k | Derivative Exercise and Retained Stock | 9,86 - 13,50 | 40,94k | 8,31% |
| 2025-12-19 | Dr. John D. QuiselCEO, President & Director | 12,30k | 12,42k | Derivative Exercise and Retained Stock | 1,01 | 56,02k | 28,14% |
| 2025-12-17 | Atlas Venture Advisors, Inc.Unternehmen | -754,00 | 68,97k | Verkauf | 91,47 | 1,51M | -0,05% |
| 2025-12-12 | Atlas Venture Advisors, Inc.Unternehmen | -177,12k | 16,22M | Verkauf | 91,18 - 93,80 | 701,46k | -20,16% |
| 2025-12-16 | Dr. Kevin J. BittermanIndependent Director | -7,00k | 548,59k | Derivative Exercise and Sale | 13,50 - 91,87 | 0,00 | - |
| 2025-12-15 | Dr. William Jacob SavageChief Medical Officer | -13,09k | 1,19M | Automatic Disposition | 90,60 - 92,23 | 37,80k | -25,73% |
| 2025-12-11 | Dr. John D. QuiselCEO, President & Director | -40,00k | 3,33M | Derivative Exercise and Sale | 9,86 - 93,65 | 43,72k | - |
| 2025-11-11 | Mr. Jonathan YuChief Opearating Officer | -30,00k | 2,46M | Derivative Exercise and Sale | 2,65 - 85,91 | 16,56k | - |
| 2025-10-22 | Access Industries, Inc.Unternehmen | -744,05k | 59,87M | Verkauf | 80,47 | 2,81M | -20,91% |
| 2025-10-15 | Atlas Venture Advisors, Inc.Unternehmen | -93,59k | 8,05M | Verkauf | 77,11 - 91,88 | 1,96M | -4,55% |
| 2025-10-07 | Atlas Venture Advisors, Inc.Unternehmen | -90,00k | 6,31M | Verkauf | 68,01 - 72,39 | 2,06M | -4,19% |
| 2025-09-09 | Dr. John D. QuiselCEO, President & Director | 10,00k | 10,10k | Derivative Exercise and Retained Stock | 1,01 | 43,72k | 29,66% |
| 2025-08-22 | Atlas Venture Advisors, Inc.Unternehmen | -2,29k | 139,58k | Automatic Disposition | 61,03 | 2,15M | -0,11% |
| 2025-08-13 | Atlas Venture Advisors, Inc.Unternehmen | -32,17k | 1,97M | Automatic Disposition | 60,99 - 61,15 | 2,15M | -1,48% |
| 2025-08-05 | Atlas Venture Advisors, Inc.Unternehmen | -395,00 | 24,08k | Automatic Disposition | 60,95 | 2,18M | -0,02% |
| 2025-07-30 | Atlas Venture Advisors, Inc.Unternehmen | -8,49k | 518,35k | Automatic Disposition | 61,04 | 2,50M | -0,34% |
| 2025-07-23 | Atlas Venture Advisors, Inc.Unternehmen | -42,87k | 2,62M | Verkauf | 60,97 - 61,17 | 2,51M | -1,68% |
| 2025-07-18 | Atlas Venture Advisors, Inc.Unternehmen | -664,00 | 40,59k | Verkauf | 61,13 | 2,55M | -0,03% |
| 2025-07-17 | Ms. Jean M. FranchiCFO | -2,03k | 119,83k | Automatic Disposition | 59,00 | 0,00 | -100,00% |
| 2025-07-10 | Ms. Jean M. FranchiCFO | -2,00k | 115,00k | Automatic Disposition | 57,50 | 2,03k | -49,62% |
| 2025-07-09 | Dr. John D. QuiselCEO, President & Director | -34,80k | 1,58M | Derivative Exercise and Sale | 9,86 - 56,20 | 33,72k | - |
| 2025-07-03 | Dr. John D. QuiselCEO, President & Director | -5,20k | 235,18k | Derivative Exercise and Sale | 9,86 - 55,09 | 33,72k | - |
| 2025-06-27 | Dr. William Jacob SavageChief Medical Officer | 32,07k | 316,21k | Derivative Exercise and Retained Stock | 9,86 | 50,89k | 170,37% |
| 2025-06-16 | Ms. Jean M. FranchiCFO | -2,00k | 104,52k | Automatic Disposition | 52,26 | 4,03k | -33,16% |
| 2025-06-06 | Dr. William Jacob SavageChief Medical Officer | -3,00k | 149,80k | Automatic Disposition | 50,00 | 18,82k | -13,73% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
